J&J: Now Master Over Mentor (MNT, JNJ)

Health and Healthcare

Published: December 1, 2008 8:21 am

Last Updated: April 28, 2020 12:15 am

If you thought that high-premium buyouts or M&A was dead, that is not the case in at least some opportunities. Mentor Corp. (NYSE: MNT) has just secured a major premium buyout this Monday morning with Johnson & Johnson (NYSE: JNJ) as the suitor.

Mentor will be acquired for approximately $1.07 billion in a cash tender offer valued at $31.00 per share.

Mentor Corporation is in the development, manufacturing, licensing, andmarketing of various products for the aesthetic and general surgerymarkets. The company will operate as a stand-alone business unit underJ&J’s ETHICON, Inc. unit, a provider of suture, mesh and otherproducts for a wide range of surgical procedures. One of Mentor’soperations it is best known for is its breast augmentation andreconstruction operations.

This is actually a near-100% buyout premium. Shares of Mentor closedat $16.15 on Friday, and the 52-week trading range is $13.33 to $40.82.

Jon C. Ogg
December 1, 2008

ALERT: Take This Retirement Quiz Now (Sponsored)

Take the quiz below to get matched with a financial advisor today.

Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.

Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future

Take the retirement quiz right here.